Autonomic Nervous System Drugs Practice Questions

Q: All of the following are nonselective beta-blockers with additional actions, except?

Betoxalol. **Explanation** The question tests the classification of beta-blockers based on their receptor selectivity and additional pharmacological properties (Vasodilatory or Pleiotropic effects). **1. Why Betaxolol is the correct answer:** Betaxolol is a **highly selective $\beta_1$-blocker** (second generation). It does not belong to the nonselective category. While it is used topically in glaucoma due to its membrane-stabilizing activity, it lacks the significant "additional" vasodilatory actions (like $\alpha$-blockade or nitric oxide release) characteristic of the third-generation beta-blockers listed in the other options. **2. Analysis of Incorrect Options:** * **Carvedilol:** A nonselective $\beta$-blocker with **$\alpha_1$-blocking** activity. It also possesses antioxidant and calcium-channel blocking properties, making it a mainstay in chronic heart failure management. * **Carteolol:** A nonselective $\beta$-blocker with **Intrinsic Sympathomimetic Activity (ISA)**. It is unique because it also acts as a $\beta_2$-agonist, which helps in reducing intraocular pressure while potentially causing less bradycardia. * **Labetalol:** A nonselective $\beta$-blocker with additional **$\alpha_1$-blocking** activity (ratio of $\alpha:\beta$ is 1:3 for oral and 1:7 for IV). It is a drug of choice for hypertensive emergencies and pregnancy-induced hypertension. **Clinical Pearls for NEET-PG:** * **Third-generation Vasodilatory Beta-blockers:** * *Nonselective:* Labetalol, Carvedilol, Carteolol, Bucindolol. * *$\beta_1$ Selective:* Nebivolol (via NO release), Celiprolol, Betaxolol (minimal). * **Nebivolol** is the most $\beta_1$-selective blocker currently available. * **Esmolol** is the shortest-acting $\beta$-blocker (half-life ~9 mins) due to metabolism by RBC esterases. * **Sotalol** is a nonselective $\beta$-blocker that also acts as a Class III antiarrhythmic (K+ channel blocker).

Q: Which drug inhibits the rate-limiting step of acetylcholine synthesis?

Hemicholinium. **Explanation:** The synthesis of Acetylcholine (ACh) occurs in the cholinergic nerve terminal [1], [5]. The **rate-limiting step** in this process is the **uptake of Choline** from the extracellular space into the neuron via a high-affinity sodium-dependent choline transporter (CHT1) [2], [4], [5]. * **Hemicholinium (Correct Answer):** This drug competitively inhibits the CHT1 transporter, blocking the entry of choline into the nerve terminal [3], [5]. Since choline availability is the bottleneck for synthesis, Hemicholinium effectively halts the production of new ACh [4]. **Analysis of Incorrect Options:** * **Vesamicol:** This drug inhibits the **VAT (Vesicle-Associated Transporter)** [5]. It prevents the storage of synthesized ACh into synaptic vesicles [3], but it does not affect the synthesis itself. * **Botulinum toxin:** This toxin acts on the presynaptic membrane to degrade **SNARE proteins** (like SNAP-25). This prevents the fusion of vesicles with the membrane, thereby inhibiting the **release** of ACh, not its synthesis [5]. * **Cocaine:** This drug primarily acts on the adrenergic system. It inhibits the **reuptake (Uptake-1)** of Norepinephrine (NE) from the synaptic cleft, prolonging its action. It has no direct role in ACh synthesis. **NEET-PG High-Yield Pearls:** * **Rate-limiting step of Catecholamine synthesis:** Tyrosine hydroxylase (inhibited by Metyrosine). * **Rate-limiting step of ACh synthesis:** Choline uptake (inhibited by Hemicholinium) [2]. * **Black Widow Spider Venom (Latrotoxin):** Causes massive, explosive release of ACh, leading to depletion. * **ACh Breakdown:** Unlike NE (which is mostly recycled via reuptake), ACh action is terminated primarily by enzymatic degradation via **Acetylcholinesterase (AChE)** in the synaptic cleft [2].

Q: Which of the following is an intermediate acting non-depolarizing neuromuscular blocking agent?

Pancuronium. **Explanation:** The classification of non-depolarizing neuromuscular blocking agents (NMBAs) is primarily based on their duration of action. **Correct Answer: A. Pancuronium** Pancuronium is a long-acting steroid-based NMBA. It typically has a duration of action exceeding 60–90 minutes. It is primarily excreted by the kidneys and is known for its vagolytic effect, which can cause tachycardia. **Analysis of Incorrect Options:** * **B. Vecuronium:** This is an **intermediate-acting** agent (duration 30–45 minutes). It is an analogue of pancuronium but lacks the vagolytic effects and is primarily metabolized by the liver. * **C. Rocuronium:** This is also an **intermediate-acting** agent. It is unique due to its rapid onset of action (60–90 seconds), making it the drug of choice for Rapid Sequence Induction (RSI) when Succinylcholine is contraindicated. * **D. Atracurium:** This is an **intermediate-acting** benzylisoquinolone. It is notable for undergoing **Hofmann elimination** (spontaneous degradation at body temperature and pH), making it safe for patients with renal or hepatic failure. **High-Yield Clinical Pearls for NEET-PG:** * **Long-acting:** Pancuronium, Doxacurium, Pipecuronium. * **Intermediate-acting:** Vecuronium, Rocuronium, Atracurium, Cisatracurium. * **Short-acting:** Mivacurium (metabolized by plasma cholinesterase). * **Ultra-short acting:** Succinylcholine (the only depolarizing agent used clinically). * **Drug of Choice in Renal Failure:** Cisatracurium (least histamine release and undergoes Hofmann elimination). * **Reversal Agent:** Sugammadex is a specific reversal agent for the steroidal NMBAs (Rocuronium > Vecuronium > Pancuronium).

Q: Why is pyridostigmine preferred in the management of myasthenia gravis?

It has a longer duration of action than neostigmine.. **Explanation:** **1. Why Option B is Correct:** Pyridostigmine is the drug of choice for the long-term oral maintenance of Myasthenia Gravis (MG). The primary reason is its **pharmacokinetics**: it has a longer duration of action (3–6 hours) compared to neostigmine (2–4 hours). This allows for less frequent dosing, which is crucial for maintaining stable muscle strength throughout the day and improving patient compliance. Additionally, pyridostigmine has a more gradual onset and offset, leading to fewer "fluctuations" in muscle power. **2. Why Other Options are Incorrect:** * **Option A:** While it is true that pyridostigmine (a quaternary ammonium compound) does not cross the blood-brain barrier (BBB), this is **not** the reason it is preferred *over* neostigmine. Neostigmine is also a quaternary ammonium compound and also does not cross the BBB. * **Option C:** Incorrect. Both pyridostigmine and neostigmine are polar molecules and do not cross the BBB. If they did, they would cause unwanted central cholinergic side effects. * **Option D:** Incorrect. Pyridostigmine has a longer, not shorter, duration of action than neostigmine. **3. High-Yield NEET-PG Pearls:** * **Edrophonium (Tensilon Test):** Used for diagnosis of MG due to its very short duration (5–10 mins). * **Neostigmine:** Preferred for reversing neuromuscular blockade (post-surgery) and paralytic ileus due to its faster onset. * **Physostigmine:** The only clinically used anticholinesterase that **crosses the BBB** (tertiary amine); used as an antidote for Atropine poisoning. * **Cholinergic Crisis vs. Myasthenic Crisis:** If a patient's weakness worsens after an Edrophonium test, it is a Cholinergic Crisis (overdose); if it improves, it is a Myasthenic Crisis (underdose).

Q: Which of the following is a depolarizing muscle relaxant?

Scoline. ### Explanation **Correct Answer: A. Scoline** **Mechanism of Action:** Scoline (Succinylcholine or Suxamethonium) is the only **depolarizing neuromuscular blocking agent** used clinically. It works by mimicking the action of acetylcholine (ACh) at the nicotinic receptors of the motor endplate. Unlike ACh, it is not metabolized by acetylcholinesterase, leading to persistent depolarization. This results in initial muscle twitching (**fasciculations**) followed by flaccid paralysis because the post-junctional membrane becomes unresponsive to further stimuli (Phase I block). **Analysis of Incorrect Options:** * **B. Ketamine:** This is an **intravenous induction agent** known as a dissociative anesthetic. It acts primarily as an NMDA receptor antagonist and has no muscle relaxant properties. * **C. Halothane:** This is a **volatile inhalation anesthetic**. While it may provide some degree of uterine relaxation and potentiate neuromuscular blockers, it is not a muscle relaxant itself. * **D. Atracurium:** This is a **non-depolarizing muscle relaxant** (NDMR). It acts as a competitive antagonist at the nicotinic receptors, preventing ACh from binding. It is notable for being metabolized via **Hofmann elimination**. **High-Yield Clinical Pearls for NEET-PG:** * **Onset/Duration:** Scoline has the fastest onset (30–60 seconds) and shortest duration (5–10 minutes), making it the drug of choice for **Rapid Sequence Induction (RSI)**. * **Metabolism:** It is metabolized by **Pseudocholinesterase** (Plasma cholinesterase). Deficiency in this enzyme leads to prolonged apnea. * **Side Effects:** Important complications include hyperkalemia (avoid in burn/trauma patients), muscle soreness, increased intraocular pressure, and it is a potent trigger for **Malignant Hyperthermia**.

Question 1

All of the following are nonselective beta-blockers with additional actions, except?

Accepted Answer

Betoxalol

Answer

Carvedilol

Answer

Caeolol

Answer

Labetalol

Question 2

Which drug inhibits the rate-limiting step of acetylcholine synthesis?

Accepted Answer

Hemicholinium

Answer

Vesamicol

Answer

Botulinum toxin

Answer

Cocaine

Question 3

Dihydroergotamine differs from ergotamine in which of the following respects?

Accepted Answer

It is a more potent alpha-adrenergic blocker and less potent vasoconstrictor.

Answer

It is a more potent oxytocic.

Answer

It has antiemetic properties.

Answer

It has high oral bioavailability.

Question 4

Which of the following is an intermediate acting non-depolarizing neuromuscular blocking agent?

Accepted Answer

Pancuronium

Answer

Vecuronium

Answer

Rocuronium

Answer

Atracurium

Question 5

Why is pyridostigmine preferred in the management of myasthenia gravis?

Accepted Answer

It has a longer duration of action than neostigmine.

Answer

It does not cross the blood-brain barrier.

Answer

It crosses the blood-brain barrier.

Answer

It has a shorter duration of action than neostigmine.

Question 6

Which of the following sympathetic receptors mediates both vasoconstriction and vasodilation?

Accepted Answer

Alpha 1 and Beta 2

Answer

Alpha 1 and Alpha 2

Answer

Alpha 1 and Beta 1

Answer

Beta 1 and Beta 2

Question 7

Which tissues are most sensitive to atropine?

Accepted Answer

The salivary, bronchial, and sweat glands

Answer

The gastric parietal cells

Answer

Smooth muscle and autonomic effectors

Answer

The heart

Question 8

A patient who has undergone limb amputation is advised a stress test. What is the drug commonly used for this test?

Accepted Answer

Dobutamine

Answer

Dopexamine

Answer

Dopamine

Answer

Dipevefrine

Question 9

Succinylcholine is short-acting due to which of the following mechanisms?

Accepted Answer

Rapid hydrolysis

Answer

Rapid excretion

Answer

Poor absorption

Answer

None of the above

Question 10

Which of the following is a depolarizing muscle relaxant?

Accepted Answer

Scoline

Answer

Ketamine

Answer

Halothane

Answer

Atracurium

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?